The Clinical Study Of Ningnaotang In Relieving Cerebral Edema At The Acute Hemorrhagic Apoplexy Stage.

Objective: To study Ningnaotang relieve cerebral edema patients with acute cerebral hemorrhage and the effect on C-reactive protein (CRP)and FIB. Methods: 40 cases with acute cerebral hemorrhage were divided into two groups at random,that is, the test group which have 21 cases and the control group which have 19 cases. The change of encephaledema and cephalophyma , the content of CRP and FIB,Chinese medicine symptom integral and NIHSS scores were examined in different periods after taking ningnaotang. Results: Compared with the control group, the content of CRP and FIB in the test group are obviously lower than the control group on the fourth after hemorrhage. Chinese medicine symptom integral and NIHSS scores in the test group are also lower than the control group on the fourth and the seventh day. The volume of encephaledema and cephalophyma in the test group are smaller than the control group Therefore, all differences have statistics significance. Conclusion: Ningnaotang have curative effects on cerebral edema at the Acute hemorrhagic Apoplexy Stage.So the dosis and the side effect of mannit were decreased. Ningnaotang has an effect on the content changes of CRP and FIB, the state of illness of the patients with acute cerebral hemorrhage. This investigation show Ningnaotang is helpful to the prognosis and curative effect for patients with acute cerebral hemorrhage...